NewEdge Wealth LLC Acquires Shares of 6,258 HCA Healthcare, Inc. $HCA

NewEdge Wealth LLC purchased a new stake in shares of HCA Healthcare, Inc. (NYSE:HCAFree Report) during the 2nd quarter, Holdings Channel.com reports. The fund purchased 6,258 shares of the company’s stock, valued at approximately $2,440,000.

A number of other hedge funds have also recently bought and sold shares of HCA. Nomura Asset Management Co. Ltd. lifted its position in HCA Healthcare by 6.2% during the 4th quarter. Nomura Asset Management Co. Ltd. now owns 64,237 shares of the company’s stock valued at $29,990,000 after purchasing an additional 3,724 shares during the period. Advisors Capital Management LLC lifted its holdings in HCA Healthcare by 61.5% in the fourth quarter. Advisors Capital Management LLC now owns 6,836 shares of the company’s stock valued at $3,192,000 after buying an additional 2,604 shares during the period. Arrowstreet Capital Limited Partnership grew its holdings in HCA Healthcare by 11.9% during the 4th quarter. Arrowstreet Capital Limited Partnership now owns 2,311,112 shares of the company’s stock worth $1,078,966,000 after acquiring an additional 245,887 shares during the period. Liberty Wealth Management LLC bought a new stake in shares of HCA Healthcare during the 4th quarter valued at $1,905,000. Finally, Sunbelt Securities Inc. grew its stake in shares of HCA Healthcare by 171.7% during the first quarter. Sunbelt Securities Inc. now owns 6,242 shares of the company’s stock worth $2,954,000 after purchasing an additional 3,945 shares during the period. 62.73% of the stock is currently owned by institutional investors.

HCA Healthcare Stock Performance

Shares of HCA opened at $406.33 on Friday. The firm’s 50 day moving average price is $396.32 and its two-hundred day moving average price is $444.25. HCA Healthcare, Inc. has a twelve month low of $353.99 and a twelve month high of $556.52. The firm has a market cap of $87.97 billion, a P/E ratio of 13.60, a PEG ratio of 1.41 and a beta of 1.10.

HCA Healthcare (NYSE:HCAGet Free Report) last posted its quarterly earnings data on Friday, July 24th. The company reported $7.59 EPS for the quarter, beating the consensus estimate of $7.56 by $0.03. The business had revenue of $20.23 billion for the quarter, compared to analysts’ expectations of $19.76 billion. HCA Healthcare had a net margin of 8.77% and a negative return on equity of 244.79%. The firm’s revenue was up 8.7% compared to the same quarter last year. During the same period in the previous year, the firm posted $6.84 EPS. On average, sell-side analysts anticipate that HCA Healthcare, Inc. will post 29.47 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, September 30th. Investors of record on Wednesday, September 16th will be given a $0.78 dividend. This represents a $3.12 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date of this dividend is Wednesday, September 16th. HCA Healthcare’s dividend payout ratio (DPR) is currently 10.45%.

Wall Street Analyst Weigh In

HCA has been the topic of a number of recent analyst reports. Royal Bank Of Canada restated an “outperform” rating and set a $435.00 target price on shares of HCA Healthcare in a report on Monday, July 27th. TD Cowen cut their price target on shares of HCA Healthcare from $500.00 to $431.00 and set a “buy” rating on the stock in a research report on Monday, June 22nd. Raymond James Financial set a $528.00 target price on shares of HCA Healthcare in a research note on Tuesday, July 7th. Cantor Fitzgerald decreased their price target on shares of HCA Healthcare from $588.00 to $525.00 and set an “overweight” rating for the company in a report on Tuesday, July 7th. Finally, Stephens dropped their price objective on HCA Healthcare from $560.00 to $530.00 and set an “overweight” rating on the stock in a research note on Monday, April 27th. Fourteen equities research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, HCA Healthcare has a consensus rating of “Moderate Buy” and an average target price of $462.64.

Get Our Latest Stock Report on HCA Healthcare

About HCA Healthcare

(Free Report)

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.

Read More

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCAFree Report).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.